Source: Zendo In an open letter to MR Mehra, SS Desai, F Ruschitzka, and AN Patel, authors of “Hydroxychloroquine or chloroquine with or without a
Source: Global Research A few years ago the British medical journal, The Lancet, published a paper touting the safety of HCQ. But this was before HCQ
Source: Mediterranee Infection Why this discrepancy between the preprint version and the version published in the BMJ? Tang et al. – Data (text and figures) evidencing
Source: MedRxiv Repurposed drugs that are immediately available and have a good safety profile constitute a first line of defence against new viral infections. Despite
Source: Science Direct Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is used in the treatment of COVID-19. Methods We retrospectively report
TRANSLATED: ZINFOS974 The request to the State Council of Me Krikorian gave rise to an order made this Wednesday, April 22, which, in its reasons,
Response to Magagnoli, MedRxiv, 2020 Matthieu MILLION1,2, Yanis ROUSSEL1,2, Didier RAOULT1,2 1 IHU-Méditerranée Infection, Marseille, France 2 Aix Marseille Univ, IRD, AP-HM, MEPHI, Marseille, France
Given the speed of evolution of the epidemic and the permanent information needs of the scientific community, combined with the difficulty of travel, the IHU
Source: Science Direct PhilippeGautretab1Jean-ChristopheLagierac1PhilippeParolaabVan ThuanHoangabdLineMeddebaJacquesSevestreaMorganeMailheaBarbaraDoudieraCamilleAubryaSophieAmraneaPisethSengaMarieHocquartaCaroleEldinabJulieFinanceeVera EstevesVieiraaHervé TissotTissot-DupontacStéphaneHonoréfgAndreasSteinacMatthieuMillionacPhilippeColsonacBernardLa ScolaacVéroniqueVeithAlexisJacquieriJean-ClaudeDeharojMichelDrancourtacPierre EdouardFournierabJean-MarcRolainacPhilippeBrouquiacDidierRaoultac aIHU-Méditerranée Infection, Marseille, France bAix Marseille Univ, IRD, AP-HM, SSA, VITROME, Marseille, France cAix Marseille Univ,
Professor Didier Raoult has reserved for the President of the Republic the exclusivity of his follow-up study on 1,061 patients passed through his services. Virologic healing
Source: TechStartUps As coronavirus death toll continues to rise around the world, there is a growing call for the use of use of hydroxychloroquine for treatment of
On March 19, we published a story about a trial study conducted by French researchers which showed a combination of Hydroxychloroquine (brand name Plaquenil) and Azithromycin to be effective
Source: National Library of Medicine Conclusion: Despite its small sample size our survey shows that hydroxychloroquine treatment is significantly associated with viral load reduction/disappearance in COVID-19
French research team Colson, Rolain, Raoult propose the following in the International Journal of Antimicrobial Agents: In the current episode of novel coronavirus (SARS-CoV-2) emergence [2],
Hydroxychloroquine (HCQ) appears as an additional therapy, as it possesses immunomodulatory and anti-thrombotic various effects [4-16].
